Azelastine Hydrochloride Spray, Metered
Product Images NDC 72603-611

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Azelastine Hydrochloride (NDC 72603-611). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure A (Azelastine Fig1)

Figure A (Azelastine Fig1)
This is a diagram showing a dust cover with a spray pump unit attached. It includes components like a safety clip, shoulders, and a bottle. The figure labeled as "Figure A" illustrates the positioning of these parts.*
FDA Label Image

Figure B (Azelastine Fig2)

Figure B (Azelastine Fig2)
FDA Label Image

Figure C (Azelastine Fig3)

Figure C (Azelastine Fig3)
FDA Label Image

Figure D (Azelastine Fig4)

Figure D (Azelastine Fig4)
FDA Label Image

Figure E (Azelastine Fig5)

Figure E (Azelastine Fig5)
FDA Label Image

Figure F And Figure G (Azelastine Fig6)

Figure F And Figure G (Azelastine Fig6)
FDA Label Image

Package Label-principal Display Panel (0.1% Container Label (30 mL Bottle))

Package Label-principal Display Panel (0.1% Container Label (30 mL Bottle))
This is a description of Azelastine Hydrochloride Nasal Spray, with a dosage of 137 mcg per spray and 200 metered sprays in total. It is for intranasal use only and should not be sprayed in the eyes. The spray contains azelastine hydrochloride USP, benzalkonium chloride, citric acid monohydrate, disodium hydrogen phosphate dodecahydrate, edetate disodium, hypromellose, purified water, and sodium chloride. The instructions recommend an initial priming of 4 sprays, followed by 2 sprays or until a fine mist appears for repriming. The product should be stored upright at room temperature, protected from freezing, tightly closed, and out of reach of children. The packaging includes additional information such as GTIN, Serial Number, Expiry Date, and LOT, along with manufacturing details for Northstar Rx LLC and APL Healthcare Limited in India.*
FDA Label Image

Package Label-principal Display Panel (0.1% Container Carton Label (30 mL Bottle))

Package Label-principal Display Panel (0.1% Container Carton Label (30 mL Bottle))
This text appears to be a detailed description of a nasal spray product containing Azelastine Hydrochloride. It includes information such as dosage instructions, usage guidelines, storage requirements, and the manufacturer details. The product is a nasal spray intended for intranasal use only and comes in a 30mL dispensing package. It also mentions unique serial numbers on each carton, batch details, and the importance of following enclosed patient instructions for use. Additionally, it lists the ingredients contained in the nasal spray, including benzalkonium chloride and various other substances. The text provides contact information for assistance and states that the product is manufactured in India.*
FDA Label Image

Chemical Structure (Azelastine Str)

Chemical Structure (Azelastine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.